Clinical Trial Update: The Efficacy and Safety of Sintilimab in Combination With Multimodal Radiotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sintilimab with multimodal radiotherapy in recurrent or metastatic nasopharyngeal carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Sintilimab (sintilimab)

Snippet

Sponsor: West China Hospital | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: UNKNOWN